Arylamine N-acetyltransferases: a structural perspective. Comments regarding the BJP paper by Zhou et al., 2013.

Br J Pharmacol

Univ Paris Diderot, Sorbonne Paris Cité, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.

Published: January 2014

This letter is a comment on Zhou . (2013). Arylamine N-acetyltransferases: a structural perspective. Br J Pharmacol 169: 748–760. To view this article visit http://dx.doi.org/10.1111/bph.12182

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874713PMC
http://dx.doi.org/10.1111/bph.12273DOI Listing

Publication Analysis

Top Keywords

arylamine n-acetyltransferases
8
n-acetyltransferases structural
8
structural perspective
8
zhou 2013
8
perspective comments
4
comments bjp
4
bjp paper
4
paper zhou
4
2013 letter
4
letter comment
4

Similar Publications

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.

Pharmacol Rev

February 2024

School of Biomedical Sciences (C.C., M.K.G., C.E.M., N.J.B., F.J.S., R.F.M.) and Australian Institute for Bioengineering and Nanotechnology (S.T.N.), University of Queensland, Brisbane, Australia.

In humans, there are two arylamine N-acetyltransferase genes that encode functional enzymes ( and ) as well as one pseudogene, all of which are located together on chromosome 8. Although they were first identified by their role in the acetylation of drugs and other xenobiotics, recent studies have shown strong associations for both enzymes in a variety of diseases, including cancer, cardiovascular disease, and diabetes. There is growing evidence that this association may be causal.

View Article and Find Full Text PDF

There are two human arylamine -acetyltransferases (NAT1 and NAT2) that have evolved separately and differ in their substrate specificity and tissue localization. In addition to its acetyltransferase activity, NAT1 can hydrolyze acetyl coenzyme A to coenzyme A in the presence of folate. Here, we show that NAT1 is rapidly inactivated at temperatures above 39 °C whereas NAT2 is more stable.

View Article and Find Full Text PDF

Background/aim: Arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) are drug-metabolizing enzymes that play a key role in the development of acute lymphoblastic leukemia (ALL).

Materials And Methods: This study evaluated NAT1 and NAT2 mRNA and protein expression and their enzymatic activity in peripheral blood mononuclear cells (PBMC) from patients with ALL (n=20) and healthy children (n=19) and explored the mechanisms that regulate these enzymes in ALL such as microRNAs (miR-1290, miR-26b) and SNPs.

Results: PBMC from patients with ALL showed a decrease in NAT1 mRNA and protein expression.

View Article and Find Full Text PDF

Function, structure, evolution, regulation of a potent drug target, arylalkylamine N-acetyltransferase.

Adv Protein Chem Struct Biol

March 2023

Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, Hainan, P.R. China; One Health Institute, Hainan University, Haikou, Hainan, P.R. China. Electronic address:

Arylalkylamine N-acetyltransferase (aaNAT) catalyzes the transacetylation of acetyl coenzyme A to arylamines and arylalkylamines. Based on three-dimensional structural information, aaNAT belongs to the GCN5-related N-acetyltransferases superfamily with a conserved acetyl-CoA binding domain (Dyda et al., 2000).

View Article and Find Full Text PDF

Molecular and Functional Characterization of -Acetyltransferases in Common Marmosets and Pigs.

Drug Metab Dispos

November 2022

Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (Y.U., M.I., A.A., M.S.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan(S.U., K.B., N.M., H.Y.); and School of Veterinary Medicine, Kitasato University, Aomori, Japan (H.K.)

Arylamine -acetyltransferases (NATs) are drug-metabolizing enzymes that are essential for the metabolism of endogenous substrates and xenobiotics. The molecular characteristics of NATs have been extensively investigated in humans but remain to be investigated in common marmosets and pigs, animal species that are often used in drug metabolism studies. In this study, marmoset NAT1 and pig NAT1 cDNAs were isolated from liver samples and were characterized by molecular analyses and drug-metabolism assays.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!